Related Experiment Videos
Protein expression -- CHI's Ninth Annual Conference.
1Biomethodes SA, Genavenir 8, 5 rue Henri Desbrueres, Evry F-91030, France. ingrid.marchal@biomethodes.com
Idrugs : the Investigational Drugs Journal
|March 9, 2006
Summary
This meeting focused on soluble protein expression for structural studies and therapeutic production. New tools and strategies were presented to improve protein expression quantity and quality.
Area of Science:
- Biotechnology and Pharmaceutical Sciences
- Protein Expression and Engineering
Background:
- The annual PepTalk event featured a 2-day meeting focused on protein expression challenges.
- Strong attendance from major pharmaceutical and biotechnology companies highlighted industry interest.
Framework:
- The meeting addressed the primary need for soluble protein expression for structural biology.
- A secondary focus was on industrial-scale production of therapeutic proteins.
Implementation:
- Suppliers introduced novel tools for screening, optimization, and scale-up of protein expression.
- Strategies were shared to overcome bottlenecks in achieving high-yield, high-quality protein expression.
Implications:
- Advancements in protein expression technologies are crucial for drug discovery and development.
- Improved methods can accelerate the production of therapeutic proteins for clinical applications.